| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
2 companies
Gibson Christopher is a Director at RECURSION PHARMACEUTICALS, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $3.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 40,000 | $4.25 | $170,000.00 | -4.1% | -27.9% | - | |
| Dec 19, 2025 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 40,000 | $4.50 | $180,000.00 | -4.2% | -20.9% | - | |
| Dec 4, 2025 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 40,000 | $4.63 | $185,200.00 | -4.1% | -26.0% | - | |
| Nov 19, 2025 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 40,000 | $4.16 | $166,400.00 | -4.2% | -14.1% | - | |
| Nov 4, 2025 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 40,000 | $5.21 | $208,400.00 | -3.9% | -16.4% | - | |
| Oct 23, 2025 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 100,000 | $5.70 | $570,000.00 | -9.5% | -19.5% | - | |
| Oct 10, 2025 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 100,000 | $6.04 | $604,000.00 | -9.3% | -11.7% | - | |
| Sep 25, 2025 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 100,000 | $4.76 | $476,000.00 | -9.5% | -5.0% | - | |
| Sep 10, 2025 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 100,000 | $4.71 | $471,000.00 | -9.3% | +5.1% | - | |
| Aug 26, 2025 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 100,000 | $4.84 | $484,000.00 | -9.5% | -10.4% | - |